PriceTargets.com logo

Moolec Science - MLEC Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $5.50
  • Forecasted Upside: 279.31%
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$1.45 As of 04/26/2024 09:53 PM ET
▲ +0.03 (2.11%)

This chart shows the closing price for MLEC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Moolec Science Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MLEC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MLEC

Analyst Price Target is $5.50
▲ +279.31% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Moolec Science in the last 3 months. The average price target is $5.50, with a high forecast of $6.00 and a low forecast of $5.00. The average price target represents a 279.31% upside from the last price of $1.45.

This chart shows the closing price for MLEC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 3 contributing investment analysts is to buy stock in Moolec Science. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/6/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/4/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/5/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/3/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/1/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/30/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/30/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/29/2024

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/30/2024Maxim GroupInitiated CoverageBuy$6.00Low
9/27/2023Roth CapitalReiterated RatingBuyLow
9/27/2023Roth MkmInitiated CoverageBuy$5.00Low
(Data available from 4/29/2019 forward)

News Sentiment Rating

0.65 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/2/2023
  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/1/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/1/2023
  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/31/2023
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/30/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/29/2024
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/30/2024
  • 4 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
4/29/2024

Current Sentiment

  • 4 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Moolec Science logo
Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.
Read More

Today's Range

Now: $1.45
Low: $1.33
High: $1.51

50 Day Range

MA: $1.53
Low: $1.19
High: $2.47

52 Week Range

Now: $1.45
Low: $1.15
High: $4.40

Volume

308,700 shs

Average Volume

1,343,707 shs

Market Capitalization

$54.47 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Moolec Science?

The following Wall Street sell-side analysts have issued stock ratings on Moolec Science in the last year: Maxim Group, Roth Capital, and Roth Mkm.
View the latest analyst ratings for MLEC.

What is the current price target for Moolec Science?

2 Wall Street analysts have set twelve-month price targets for Moolec Science in the last year. Their average twelve-month price target is $5.50, suggesting a possible upside of 279.3%. Maxim Group has the highest price target set, predicting MLEC will reach $6.00 in the next twelve months. Roth Mkm has the lowest price target set, forecasting a price of $5.00 for Moolec Science in the next year.
View the latest price targets for MLEC.

What is the current consensus analyst rating for Moolec Science?

Moolec Science currently has 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe MLEC will outperform the market and that investors should add to their positions of Moolec Science.
View the latest ratings for MLEC.

What other companies compete with Moolec Science?

Other companies that are similar to Moolec Science include Grove Collaborative, Lee Enterprises, Tupperware Brands, Virgin Group Acquisition Corp. II and Oxus Acquisition. Learn More about companies similar to Moolec Science.

How do I contact Moolec Science's investor relations team?

Moolec Science's physical mailing address is 2735 SAND HILL ROAD SUITE 110, MENLO PARK CA, 94025. The company's listed phone number is 650-515-3930 and its investor relations email address is [email protected]. The official website for Moolec Science is moolecscience.com. Learn More about contacing Moolec Science investor relations.